| UniProt ID | CNOT4_HUMAN | |
|---|---|---|
| UniProt AC | O95628 | |
| Protein Name | CCR4-NOT transcription complex subunit 4 | |
| Gene Name | CNOT4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 575 | |
| Subcellular Localization | Cytoplasm . Nucleus . | |
| Protein Description | Has E3 ubiquitin ligase activity, promoting ubiquitination and degradation of target proteins. [PubMed: 11823428] | |
| Protein Sequence | MSRSPDAKEDPVECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPAVYKPLSQEELQRIKNEKKQKQNERKQKISENRKHLASVRVVQKNLVFVVGLSQRLADPEVLKRPEYFGKFGKIHKVVINNSTSYAGSQGPSASAYVTYIRSEDALRAIQCVNNVVVDGRTLKASLGTTKYCSYFLKNMQCPKPDCMYLHELGDEAASFTKEEMQAGKHQEYEQKLLQELYKLNPNFLQLSTGSVDKNKNKVTPLQRYDTPIDKPSDSLSIGNGDNSQQISNSDTPSPPPGLSKSNPVIPISSSNHSARSPFEGAVTESQSLFSDNFRHPNPIPSGLPPFPSSPQTSSDWPTAPEPQSLFTSETIPVSSSTDWQAAFGFGSSKQPEDDLGFDPFDVTRKALADLIEKELSVQDQPSLSPTSLQNSSSHTTTAKGPGSGFLHPAAATNANSLNSTFSVLPQRFPQFQQHRAVYNSFSFPGQAARYPWMAFPRNSIMHLNHTANPTSNSNFLDLNLPPQHNTGLGGIPVAGEEEVKVSTMPLSTSSHSLQQGQQPTSLHTTVA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSRSPDAKE ------CCCCCCCCC | 41.27 | 28464451 | |
| 2 (in isoform 2) | Phosphorylation | - | 41.27 | 21406692 | |
| 4 | Phosphorylation | ----MSRSPDAKEDP ----CCCCCCCCCCC | 21.59 | 26657352 | |
| 4 (in isoform 10) | Phosphorylation | - | 21.59 | 27251275 | |
| 67 | Phosphorylation | YPEDPAVYKPLSQEE CCCCCCCCCCCCHHH | 14.70 | 29214152 | |
| 67 (in isoform 10) | Phosphorylation | - | 14.70 | 27642862 | |
| 71 | Phosphorylation | PAVYKPLSQEELQRI CCCCCCCCHHHHHHH | 44.03 | 17525332 | |
| 71 (in isoform 10) | Phosphorylation | - | 44.03 | 24719451 | |
| 71 (in isoform 2) | Phosphorylation | - | 44.03 | - | |
| 71 (in isoform 8) | Phosphorylation | - | 44.03 | - | |
| 131 | Phosphorylation | EVLKRPEYFGKFGKI HHHCCHHHHCCCCCE | 21.95 | - | |
| 185 | Phosphorylation | NVVVDGRTLKASLGT CEEECCCEEEEECCC | 37.83 | 28270605 | |
| 189 | Phosphorylation | DGRTLKASLGTTKYC CCCEEEEECCCHHHH | 26.24 | 28270605 | |
| 192 | Phosphorylation | TLKASLGTTKYCSYF EEEEECCCHHHHHHH | 25.96 | 28270605 | |
| 193 | Phosphorylation | LKASLGTTKYCSYFL EEEECCCHHHHHHHH | 20.44 | 28270605 | |
| 195 | Phosphorylation | ASLGTTKYCSYFLKN EECCCHHHHHHHHHH | 5.64 | 28270605 | |
| 197 | Phosphorylation | LGTTKYCSYFLKNMQ CCCHHHHHHHHHHCC | 18.81 | 28270605 | |
| 198 | Phosphorylation | GTTKYCSYFLKNMQC CCHHHHHHHHHHCCC | 14.90 | 28270605 | |
| 222 | Phosphorylation | ELGDEAASFTKEEMQ ECCHHHHHCCHHHHH | 40.26 | 24719451 | |
| 239 | Ubiquitination | KHQEYEQKLLQELYK CCHHHHHHHHHHHHH | 38.94 | - | |
| 255 | Phosphorylation | NPNFLQLSTGSVDKN CCCCEECCCCCCCCC | 20.12 | 29507054 | |
| 255 (in isoform 10) | Phosphorylation | - | 20.12 | 27251275 | |
| 256 | Phosphorylation | PNFLQLSTGSVDKNK CCCEECCCCCCCCCC | 41.91 | 30576142 | |
| 256 (in isoform 2) | Phosphorylation | - | 41.91 | 29507054 | |
| 256 (in isoform 8) | Phosphorylation | - | 41.91 | 29507054 | |
| 256 (in isoform 9) | Phosphorylation | - | 41.91 | 29507054 | |
| 258 | Phosphorylation | FLQLSTGSVDKNKNK CEECCCCCCCCCCCC | 27.51 | 30576142 | |
| 258 (in isoform 2) | Phosphorylation | - | 27.51 | 21406692 | |
| 258 (in isoform 8) | Phosphorylation | - | 27.51 | 25159151 | |
| 258 (in isoform 9) | Phosphorylation | - | 27.51 | 25159151 | |
| 267 (in isoform 2) | Phosphorylation | - | 21.64 | 25849741 | |
| 267 (in isoform 8) | Phosphorylation | - | 21.64 | 25849741 | |
| 267 (in isoform 9) | Phosphorylation | - | 21.64 | 25849741 | |
| 271 (in isoform 2) | Phosphorylation | - | 38.69 | 25849741 | |
| 271 (in isoform 8) | Phosphorylation | - | 38.69 | 25849741 | |
| 271 (in isoform 9) | Phosphorylation | - | 38.69 | 25849741 | |
| 277 (in isoform 2) | Phosphorylation | - | 59.00 | 21406692 | |
| 277 (in isoform 8) | Phosphorylation | - | 59.00 | 21406692 | |
| 277 (in isoform 9) | Phosphorylation | - | 59.00 | 21406692 | |
| 279 (in isoform 2) | Phosphorylation | - | 39.35 | 21406692 | |
| 279 (in isoform 8) | Phosphorylation | - | 39.35 | 21406692 | |
| 279 (in isoform 9) | Phosphorylation | - | 39.35 | 21406692 | |
| 281 (in isoform 2) | Phosphorylation | - | 63.22 | 21406692 | |
| 281 (in isoform 8) | Phosphorylation | - | 63.22 | 21406692 | |
| 281 (in isoform 9) | Phosphorylation | - | 63.22 | 21406692 | |
| 288 (in isoform 2) | Phosphorylation | - | 30.20 | 23663014 | |
| 288 (in isoform 8) | Phosphorylation | - | 30.20 | 23663014 | |
| 288 (in isoform 9) | Phosphorylation | - | 30.20 | 23663014 | |
| 291 | Phosphorylation | SIGNGDNSQQISNSD CCCCCCCCCCCCCCC | 28.35 | 27080861 | |
| 292 (in isoform 2) | Phosphorylation | - | 51.37 | 23663014 | |
| 292 (in isoform 8) | Phosphorylation | - | 51.37 | 23663014 | |
| 292 (in isoform 9) | Phosphorylation | - | 51.37 | 23663014 | |
| 294 (in isoform 2) | Phosphorylation | - | 3.06 | 23663014 | |
| 294 (in isoform 8) | Phosphorylation | - | 3.06 | 23663014 | |
| 294 (in isoform 9) | Phosphorylation | - | 3.06 | 23663014 | |
| 295 | Phosphorylation | GDNSQQISNSDTPSP CCCCCCCCCCCCCCC | 26.41 | 25159151 | |
| 296 (in isoform 2) | Phosphorylation | - | 45.60 | 23663014 | |
| 296 (in isoform 8) | Phosphorylation | - | 45.60 | 23663014 | |
| 296 (in isoform 9) | Phosphorylation | - | 45.60 | 23663014 | |
| 297 | Phosphorylation | NSQQISNSDTPSPPP CCCCCCCCCCCCCCC | 35.75 | 25159151 | |
| 298 (in isoform 2) | Phosphorylation | - | 67.87 | 23663014 | |
| 298 (in isoform 8) | Phosphorylation | - | 67.87 | 23663014 | |
| 298 (in isoform 9) | Phosphorylation | - | 67.87 | 23663014 | |
| 299 | Phosphorylation | QQISNSDTPSPPPGL CCCCCCCCCCCCCCC | 26.03 | 25159151 | |
| 301 | Phosphorylation | ISNSDTPSPPPGLSK CCCCCCCCCCCCCCC | 52.73 | 25159151 | |
| 301 (in isoform 10) | Phosphorylation | - | 52.73 | 27251275 | |
| 304 (in isoform 2) | Phosphorylation | - | 60.79 | 23663014 | |
| 304 (in isoform 8) | Phosphorylation | - | 60.79 | 23663014 | |
| 304 (in isoform 9) | Phosphorylation | - | 60.79 | 23663014 | |
| 306 (in isoform 2) | Phosphorylation | - | 7.80 | - | |
| 306 (in isoform 8) | Phosphorylation | - | 7.80 | - | |
| 307 | Phosphorylation | PSPPPGLSKSNPVIP CCCCCCCCCCCCEEE | 39.70 | 23663014 | |
| 309 | O-linked_Glycosylation | PPPGLSKSNPVIPIS CCCCCCCCCCEEECC | 42.88 | 30059200 | |
| 309 | Phosphorylation | PPPGLSKSNPVIPIS CCCCCCCCCCEEECC | 42.88 | 20068231 | |
| 316 | O-linked_Glycosylation | SNPVIPISSSNHSAR CCCEEECCCCCCCCC | 23.51 | 30059200 | |
| 316 | Phosphorylation | SNPVIPISSSNHSAR CCCEEECCCCCCCCC | 23.51 | 28464451 | |
| 317 | O-linked_Glycosylation | NPVIPISSSNHSARS CCEEECCCCCCCCCC | 35.56 | 30059200 | |
| 317 | Phosphorylation | NPVIPISSSNHSARS CCEEECCCCCCCCCC | 35.56 | 30576142 | |
| 318 | O-linked_Glycosylation | PVIPISSSNHSARSP CEEECCCCCCCCCCC | 31.60 | 30059200 | |
| 318 | Phosphorylation | PVIPISSSNHSARSP CEEECCCCCCCCCCC | 31.60 | 29507054 | |
| 318 (in isoform 2) | Phosphorylation | - | 31.60 | - | |
| 318 (in isoform 8) | Phosphorylation | - | 31.60 | - | |
| 321 | O-linked_Glycosylation | PISSSNHSARSPFEG ECCCCCCCCCCCCCC | 29.63 | 30059200 | |
| 321 | Phosphorylation | PISSSNHSARSPFEG ECCCCCCCCCCCCCC | 29.63 | 28464451 | |
| 321 (in isoform 2) | Phosphorylation | - | 29.63 | - | |
| 321 (in isoform 8) | Phosphorylation | - | 29.63 | - | |
| 324 | O-linked_Glycosylation | SSNHSARSPFEGAVT CCCCCCCCCCCCCCC | 33.39 | 30059200 | |
| 324 | Phosphorylation | SSNHSARSPFEGAVT CCCCCCCCCCCCCCC | 33.39 | 22167270 | |
| 324 (in isoform 10) | Phosphorylation | - | 33.39 | 24719451 | |
| 328 (in isoform 2) | Phosphorylation | - | 26.23 | - | |
| 328 (in isoform 8) | Phosphorylation | - | 26.23 | - | |
| 331 | O-linked_Glycosylation | SPFEGAVTESQSLFS CCCCCCCCCCHHHCC | 29.41 | 30059200 | |
| 331 | Phosphorylation | SPFEGAVTESQSLFS CCCCCCCCCCHHHCC | 29.41 | 28464451 | |
| 333 | Phosphorylation | FEGAVTESQSLFSDN CCCCCCCCHHHCCCC | 18.72 | 28450419 | |
| 335 | Phosphorylation | GAVTESQSLFSDNFR CCCCCCHHHCCCCCC | 40.43 | 28450419 | |
| 338 | Phosphorylation | TESQSLFSDNFRHPN CCCHHHCCCCCCCCC | 36.62 | 28122231 | |
| 349 | Phosphorylation | RHPNPIPSGLPPFPS CCCCCCCCCCCCCCC | 54.40 | 26074081 | |
| 356 | Phosphorylation | SGLPPFPSSPQTSSD CCCCCCCCCCCCCCC | 55.84 | 26074081 | |
| 357 | Phosphorylation | GLPPFPSSPQTSSDW CCCCCCCCCCCCCCC | 22.67 | 26074081 | |
| 360 | Phosphorylation | PFPSSPQTSSDWPTA CCCCCCCCCCCCCCC | 33.32 | 26074081 | |
| 361 | Phosphorylation | FPSSPQTSSDWPTAP CCCCCCCCCCCCCCC | 22.51 | 26074081 | |
| 362 | Phosphorylation | PSSPQTSSDWPTAPE CCCCCCCCCCCCCCC | 47.27 | 26074081 | |
| 375 | O-linked_Glycosylation | PEPQSLFTSETIPVS CCCCCCCCCCCCCCC | 30.83 | 30059200 | |
| 396 | O-linked_Glycosylation | AAFGFGSSKQPEDDL HHHCCCCCCCCCCCC | 35.37 | 30059200 | |
| 413 | Ubiquitination | DPFDVTRKALADLIE CHHHHHHHHHHHHHH | 38.08 | - | |
| 424 | Phosphorylation | DLIEKELSVQDQPSL HHHHHHCCCCCCCCC | 20.87 | 29255136 | |
| 429 (in isoform 2) | Phosphorylation | - | 45.59 | 21406692 | |
| 429 (in isoform 8) | Phosphorylation | - | 45.59 | - | |
| 430 | Phosphorylation | LSVQDQPSLSPTSLQ CCCCCCCCCCCCCCC | 35.53 | 23401153 | |
| 432 | Phosphorylation | VQDQPSLSPTSLQNS CCCCCCCCCCCCCCC | 30.39 | 29255136 | |
| 432 (in isoform 10) | Phosphorylation | - | 30.39 | 24719451 | |
| 434 | Phosphorylation | DQPSLSPTSLQNSSS CCCCCCCCCCCCCCC | 38.40 | 29255136 | |
| 435 | O-linked_Glycosylation | QPSLSPTSLQNSSSH CCCCCCCCCCCCCCC | 31.20 | 30059200 | |
| 435 | Phosphorylation | QPSLSPTSLQNSSSH CCCCCCCCCCCCCCC | 31.20 | 29255136 | |
| 439 | Phosphorylation | SPTSLQNSSSHTTTA CCCCCCCCCCCCCCC | 21.91 | 23401153 | |
| 440 | Phosphorylation | PTSLQNSSSHTTTAK CCCCCCCCCCCCCCC | 33.42 | 23927012 | |
| 441 | Phosphorylation | TSLQNSSSHTTTAKG CCCCCCCCCCCCCCC | 25.36 | 23927012 | |
| 443 | Phosphorylation | LQNSSSHTTTAKGPG CCCCCCCCCCCCCCC | 27.99 | 23927012 | |
| 444 | Phosphorylation | QNSSSHTTTAKGPGS CCCCCCCCCCCCCCC | 21.23 | 23927012 | |
| 445 | Phosphorylation | NSSSHTTTAKGPGSG CCCCCCCCCCCCCCC | 27.77 | 23927012 | |
| 475 | Asymmetric dimethylarginine | TFSVLPQRFPQFQQH HHCCCCCCCHHHHHH | 43.18 | - | |
| 475 | Methylation | TFSVLPQRFPQFQQH HHCCCCCCCHHHHHH | 43.18 | 24129315 | |
| 483 | Asymmetric dimethylarginine | FPQFQQHRAVYNSFS CHHHHHHHHHHCCCC | 22.78 | - | |
| 483 | Methylation | FPQFQQHRAVYNSFS CHHHHHHHHHHCCCC | 22.78 | 24129315 | |
| 486 | Phosphorylation | FQQHRAVYNSFSFPG HHHHHHHHCCCCCCC | 12.24 | - | |
| 488 | Phosphorylation | QHRAVYNSFSFPGQA HHHHHHCCCCCCCCH | 12.46 | 26852163 | |
| 490 | Phosphorylation | RAVYNSFSFPGQAAR HHHHCCCCCCCCHHC | 30.28 | 24260401 | |
| 490 (in isoform 10) | Phosphorylation | - | 30.28 | 27251275 | |
| 497 | Asymmetric dimethylarginine | SFPGQAARYPWMAFP CCCCCHHCCCCEECC | 40.85 | - | |
| 497 | Methylation | SFPGQAARYPWMAFP CCCCCHHCCCCEECC | 40.85 | 24129315 | |
| 505 | Methylation | YPWMAFPRNSIMHLN CCCEECCCCCCEECC | 42.97 | - | |
| 556 | Phosphorylation | VSTMPLSTSSHSLQQ EEECCCCCCCCCCCC | 41.76 | 23186163 | |
| 557 | Phosphorylation | STMPLSTSSHSLQQG EECCCCCCCCCCCCC | 23.76 | 23186163 | |
| 558 | Phosphorylation | TMPLSTSSHSLQQGQ ECCCCCCCCCCCCCC | 19.72 | 23186163 | |
| 560 | Phosphorylation | PLSTSSHSLQQGQQP CCCCCCCCCCCCCCC | 29.80 | 23186163 | |
| 597 (in isoform 4) | Methylation | - | - | ||
| 604 (in isoform 8) | Phosphorylation | - | 28152594 | ||
| 607 (in isoform 4) | Phosphorylation | - | 28152594 | ||
| 607 (in isoform 8) | Phosphorylation | - | 28152594 | ||
| 608 (in isoform 8) | Phosphorylation | - | 28152594 | ||
| 610 (in isoform 4) | Phosphorylation | - | 28152594 | ||
| 611 (in isoform 4) | Phosphorylation | - | 28152594 | ||
| 611 (in isoform 8) | Phosphorylation | - | 28152594 | ||
| 614 (in isoform 4) | Phosphorylation | - | 28152594 | ||
| 618 (in isoform 8) | Phosphorylation | - | 28152594 | ||
| 621 (in isoform 4) | Phosphorylation | - | 28152594 | ||
| 624 (in isoform 8) | Phosphorylation | - | 28111955 | ||
| 626 (in isoform 8) | Phosphorylation | - | 21815630 | ||
| 627 (in isoform 4) | Phosphorylation | - | 28111955 | ||
| 628 (in isoform 8) | Phosphorylation | - | 21815630 | ||
| 629 (in isoform 4) | Phosphorylation | - | 21815630 | ||
| 631 (in isoform 4) | Phosphorylation | - | 21815630 | ||
| 641 (in isoform 4) | Methylation | - | - | ||
| 675 (in isoform 9) | Phosphorylation | - | 28152594 | ||
| 678 (in isoform 10) | Phosphorylation | - | 28152594 | ||
| 678 (in isoform 9) | Phosphorylation | - | 28152594 | ||
| 679 (in isoform 9) | Phosphorylation | - | 28152594 | ||
| 681 (in isoform 10) | Phosphorylation | - | 28152594 | ||
| 682 (in isoform 10) | Phosphorylation | - | 28152594 | ||
| 682 (in isoform 9) | Phosphorylation | - | 28152594 | ||
| 685 (in isoform 10) | Phosphorylation | - | 28152594 | ||
| 689 (in isoform 9) | Phosphorylation | - | 28152594 | ||
| 692 (in isoform 10) | Phosphorylation | - | 28152594 | ||
| 695 (in isoform 9) | Phosphorylation | - | 28111955 | ||
| 697 (in isoform 9) | Phosphorylation | - | 21815630 | ||
| 698 (in isoform 10) | Phosphorylation | - | 28111955 | ||
| 699 (in isoform 9) | Phosphorylation | - | 21815630 | ||
| 700 (in isoform 10) | Phosphorylation | - | 21815630 | ||
| 702 (in isoform 10) | Phosphorylation | - | 21815630 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNOT4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNOT4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KDM5C_HUMAN | KDM5C | physical | 19346402 | |
| UB2D2_HUMAN | UBE2D2 | physical | 15001359 | |
| UB2E1_HUMAN | UBE2E1 | physical | 15001359 | |
| UB2E3_HUMAN | UBE2E3 | physical | 15001359 | |
| CNOT4_HUMAN | CNOT4 | physical | 15001359 | |
| UB2D2_HUMAN | UBE2D2 | physical | 11823428 | |
| UB2E1_HUMAN | UBE2E1 | physical | 11823428 | |
| UB2E3_HUMAN | UBE2E3 | physical | 11823428 | |
| UBC5_YEAST | UBC5 | physical | 11823428 | |
| CNOT4_HUMAN | CNOT4 | physical | 11823428 | |
| UB2D1_HUMAN | UBE2D1 | physical | 19346402 | |
| EP300_HUMAN | EP300 | physical | 21988832 | |
| RBM15_HUMAN | RBM15 | physical | 26575292 | |
| UB2D2_HUMAN | UBE2D2 | physical | 26575292 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-432 ANDSER-490, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND MASSSPECTROMETRY. | |